Darko Kantoci

1.1k total citations
38 papers, 905 citations indexed

About

Darko Kantoci is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Darko Kantoci has authored 38 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Organic Chemistry and 10 papers in Pharmacology. Recurrent topics in Darko Kantoci's work include Inflammatory mediators and NSAID effects (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Analytical Chemistry and Chromatography (4 papers). Darko Kantoci is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Analytical Chemistry and Chromatography (4 papers). Darko Kantoci collaborates with scholars based in United States, Croatia and United Kingdom. Darko Kantoci's co-authors include William J. Wechter, Euan Murray, Derin C. D’Amico, Douglas D. Leipold, Hasan Uludağ, Tiejun Gao, George R. Pettit, Joseph D. McCracken, K. Michael Gibson and Delbert L. Herald and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Darko Kantoci

38 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darko Kantoci United States 18 342 304 240 174 169 38 905
Yong-Ri Jin South Korea 24 149 0.4× 687 2.3× 141 0.6× 144 0.8× 164 1.0× 42 1.3k
Rémy Kachadourian United States 18 231 0.7× 618 2.0× 58 0.2× 100 0.6× 368 2.2× 20 1.3k
Ghulam M. Maharvi Pakistan 19 614 1.8× 379 1.2× 49 0.2× 174 1.0× 181 1.1× 33 1.1k
Madeleine F. Dennis United Kingdom 19 239 0.7× 335 1.1× 118 0.5× 26 0.1× 89 0.5× 27 893
Andreas Gescher United Kingdom 21 219 0.6× 451 1.5× 52 0.2× 86 0.5× 222 1.3× 51 1.2k
Shigenori Oka Japan 15 439 1.3× 406 1.3× 92 0.4× 30 0.2× 65 0.4× 25 1.1k
James M. Jamison United States 23 211 0.6× 550 1.8× 118 0.5× 68 0.4× 84 0.5× 69 1.4k
Keizo Ito Japan 15 199 0.6× 297 1.0× 41 0.2× 102 0.6× 47 0.3× 72 821
Rajagopalan Sridhar United States 17 172 0.5× 393 1.3× 41 0.2× 45 0.3× 140 0.8× 35 913
Joachim Paust Germany 14 466 1.4× 218 0.7× 126 0.5× 58 0.3× 26 0.2× 32 771

Countries citing papers authored by Darko Kantoci

Since Specialization
Citations

This map shows the geographic impact of Darko Kantoci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darko Kantoci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darko Kantoci more than expected).

Fields of papers citing papers by Darko Kantoci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darko Kantoci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darko Kantoci. The network helps show where Darko Kantoci may publish in the future.

Co-authorship network of co-authors of Darko Kantoci

This figure shows the co-authorship network connecting the top 25 collaborators of Darko Kantoci. A scholar is included among the top collaborators of Darko Kantoci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darko Kantoci. Darko Kantoci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leipold, Douglas D., et al.. (2004). Bioinversion of R‐flurbiprofen to S‐flurbiprofen at various dose levels in rat, mouse, and monkey. Chirality. 16(6). 379–387. 22 indexed citations
2.
Uludağ, Hasan, et al.. (2000). Bisphosphonate Conjugation to Proteins as a Means To Impart Bone Affinity. Biotechnology Progress. 16(2). 258–267. 61 indexed citations
3.
Wechter, William J., et al.. (2000). Treatment and survival study in the C57BL/6J-APCMin/+ (Min) mouse with R-flurbiprofen. Life Sciences. 66(8). 745–753. 55 indexed citations
4.
Uludağ, Hasan, et al.. (2000). Bone Affinity of a Bisphosphonate-Conjugated Protein in Vivo. Biotechnology Progress. 16(6). 1115–1118. 36 indexed citations
5.
Wechter, William J., et al.. (1998). Mechanism of Enhancement of Intestinal Ulcerogenicity of S-Aryl Propionic Acids by Their R-Enantiomers in the Rat. Digestive Diseases and Sciences. 43(6). 1264–1274. 12 indexed citations
6.
Kantoci, Darko, et al.. (1996). Synthesis of Aminobisphosphonate. Synthetic Communications. 26(10). 2037–2043. 40 indexed citations
7.
Kantoci, Darko & William J. Wechter. (1996). Calculation of Inversion Half‐Lives of Aryl Propionic Acid Class Nonsteroidal Antiinflammatory Drugs. The Journal of Clinical Pharmacology. 36(6). 500–504. 7 indexed citations
8.
Wechter, William J., et al.. (1996). A new endogenous natriuretic factor: LLU-alpha.. Proceedings of the National Academy of Sciences. 93(12). 6002–6007. 156 indexed citations
9.
Wechter, William J., et al.. (1996). Antiproliferative Effects of the Enantiomers of Flurbiprofen. The Journal of Clinical Pharmacology. 36(6). 540–545. 50 indexed citations
10.
Kantoci, Darko. (1996). A Study of an Empirical Equation for the Evaluation of Separation Efficiency in Chromatography. Journal of Liquid Chromatography & Related Technologies. 19(6). 853–866. 2 indexed citations
11.
Horvat, Štefica, Lidija Varga‐Defterdarovič, Jaroslav Horvat, et al.. (1995). Synthesis and bioactivity studies of 1‐adamantanamine derivatives of peptides. Journal of Peptide Science. 1(5). 303–310. 4 indexed citations
12.
Groszek, Grażyna, Darko Kantoci, & George R. Pettit. (1995). The Isolation and Structure Elucidation of Debromoaxinohydantoin. Liebigs Annalen. 1995(4). 715–716. 9 indexed citations
13.
Murray, Euan, Darko Kantoci, Derin C. D’Amico, et al.. (1995). Endogenous natriuretic factors 3: isolation and characterization of human natriuretic factors llu-α, LLU-β1, and llu-γ. Life Sciences. 57(23). 2145–2161. 16 indexed citations
14.
Pettit, George R., Sheo B. Singh, Delbert L. Herald, et al.. (1994). The Dolastatins. 17. Synthesis of Dolaproine and Related Diastereoisomers. The Journal of Organic Chemistry. 59(21). 6287–6295. 53 indexed citations
15.
Pettit, George R., Fiona Hogan, Sheo B. Singh, et al.. (1994). The Dolastatins 16. Synthesis of Dolaphenine. Heterocycles. 39(1). 81–81. 7 indexed citations
16.
Pettit, George R., et al.. (1993). Isolation of the Nickel-Chlorin Chelate Tunichlorin from the South Pacific Ocean Sea Hare Dolabella auricularia. Journal of Natural Products. 56(11). 1981–1984. 8 indexed citations
17.
Kantoci, Darko, et al.. (1992). Complexes of Fe(III) with amino sugars and small glycopeptides. Journal of Inorganic Biochemistry. 48(1). 55–62. 4 indexed citations
18.
Kantoci, Darko, D. Keglević, & Andrew E. Derome. (1989). Convenient syntheses of O-(2-acetamido-2-deoxy-β-d-glucopyranosyl)-(1→6 and 4)-N-acetylmuramoyl-l-alanyl-d-isoglutamine. Carbohydrate Research. 186(1). 77–85. 5 indexed citations
19.
Horvat, Štefica, et al.. (1989). Glycoconjugates of opioid peptides - III+. A novel regioselective synthesis of 6-O-peptidyl-d-glycopyranoses using unprotected sugars. Tetrahedron. 45(14). 4579–4584. 18 indexed citations
20.
Keglević, D., et al.. (1986). Aminolysis of N-Acetylmuramic Acid Lactones by Amino Acid and Peptide Esters - A Synthetic Route to N-Acetylmuramoylamide Derivatives. Croatica Chemica Acta. 58(4). 569–581. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026